包装
组合片
T20
PTP包装:56片(14片x2x2),140片(14片x2x5)
T25
PTP包装:56片(14片x2x2),140片(14片x2x5)
制造商和分销商
冈山大鹏制药有限公司
销售提携
大鹏药业工业株式会社
注:以上中文处方资料不够完整,使用者以原处方资料为准。
完整说明资料附件: https://www.info.pmda.go.jp/go/pack/4229101F1050_1_03/?view=frame&style=SGML&lang=ja
----------------------------------------------- Anti-tumor drug "TS-1® Combination OD Tablet T20/T25" Approved for Marketing in Japan
S-1taiho combination OD tablet T20/T25 is an anti-tumor drug "TS-1®" (generic name: Tegafur, Gemrazide, Otrexide potassium combination drug) compound anti-cancer agent. The drug is the world's first orally disintegrating tablet of an anticancer drug. Because it can quickly decompose with saliva in the mouth and can be taken without water, it can meet the needs of various patients, such as difficulty in taking capsules and limiting the amount of water consumed. A nucleated orally disintegrating tablet that reliably contains an anticancer agent component, and a preparation that both prevents the spread of the anticancer agent component and has rapid disintegration. In addition to the conventional combined capsules and granules, three dosage forms can be selected according to the patient's condition, which will improve the continuity of treatment and bring higher therapeutic effects.